Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01567150 · ClinicalTrials.gov registry record · Phase 4
Wound Fluid Protease Levels During Use of Novel Wound Dressing
A Phase 4 study, sponsored by Hollister Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT01567150: Completed Phase 4 study, sponsored by Hollister Incorporated.
NCT01567150 is a Phase 4 study that has completed, run by Hollister Incorporated. The registered enrollment target is 35 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01567150, a Phase 4 study, has completed, sponsored by Hollister Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study is being conducted to characterize the way leg wounds respond to a new type of wound dressing, compared to wounds in patients who are not using the new dressing. The investigators will collect wound fluid for biochemical analysis, and they will measure the wound healing that occurs with and without the new dressing.
Primary Outcome
Wound fluid will be collected and analyzed at baseline and approximately every 7 days. Mean was calculated for each subject. Means and standard deviation were calculated for the treatment and control groups.
Interventions
- DEVICE Novel Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
What the finished NCT01567150 record still lists
NCT01567150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Novel Dressing is the first listed.
NCT01567150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01567150 about?
NCT01567150 is a clinical study titled "Wound Fluid Protease Levels During Use of Novel Wound Dressing". This study is being conducted to characterize the way leg wounds respond to a new type of wound dressing, compared to wounds in patients who are not using the new dressing. The investigators will collect wound fluid for biochemical analysis, and they will measure the wound healing that occurs with a...
What is the current status of trial NCT01567150?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2012-02. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01567150?
The interventions under investigation include: Novel Dressing (DEVICE).
Who is sponsoring clinical trial NCT01567150?
This trial is sponsored by Hollister Incorporated, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01567150's enrollment target sits among peer trials
35 1506th of 2000 higher than 481 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia